Bevacizumab reported to increase overall survival in advanced cervical cancer

被引：0
|
作者：
Lake, Francesca
机构：
来源：
FUTURE ONCOLOGY | 2014年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：787 / 787
页数：1
相关论文
共 50 条
  • [31] FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE III RANDOMIZED TRIAL OF CHEMOTHERAPY WITH AND WITHOUT BEVACIZUMAB FOR ADVANCED CERVICAL CANCER: A NRG ONCOLOGY - GYNECOLOGIC ONCOLOGY GROUP STUDY
    Tewari, K. S.
    Sill, M. W.
    Penson, R. T.
    Huang, H.
    Ramondetta, L. M.
    Landrum, L. M.
    Oaknin, A.
    Reid, T. J.
    Leitao, M. M.
    Monk, B. J.
    Michael, H. E.
    ANNALS OF ONCOLOGY, 2014, 25
  • [32] Evaluating the Impact of Bevacizumab Maintenance Therapy on Overall Survival in Advanced Non-Small-Cell Lung Cancer
    Dranitsaris, George
    Beegle, Nancy
    Ravelo, Arliene
    Kalberer, Traci
    Yu, Elaine
    Thomas, Sachdev
    CLINICAL LUNG CANCER, 2013, 14 (02) : 120 - 127
  • [33] THE USE OF BEVACIZUMAB FOR RECURRENT OR ADVANCED CERVICAL CANCER AT OUR HOSPITAL
    Nakamura, A.
    Nakamura, A.
    Yamamoto, A.
    Miyagawa, C.
    Tokushige, Y.
    Higashiyama, N.
    Kobayashi, F.
    Yoshimizu, M.
    Nakagawa, E.
    Iwami, S.
    Nonogaki, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 349 - 349
  • [34] NEOADJUVANT CHEMOIMMUNOTHERAPY INCREASES THE OVERALL FIVE-YEAR SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
    Menshenina, A.
    Moiseenko, T.
    Frantsiyants, E.
    Verenikina, E.
    Ushakova, N.
    Adamyan, M.
    Chalabova, T.
    Selezneva, G.
    Maksimova, N.
    Pustovalova, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A70 - A70
  • [35] Patient-Reported Outcomes in a Randomized Trial of Bevacizumab in the Treatment of Advanced Cervical Cancer: a Gynecologic Oncology Group Study
    Penson, Richard T.
    Huang, Helen Q.
    Wenzel, Lari
    Tewari, Krishnansu
    Monk, Bradley J.
    Sill, Michael
    Stockman, Sharon
    Ramondetta, Lois
    Landrum, Lisa
    Oaknin, Ana
    Reid, Thomas
    Leitao, Mario
    QUALITY OF LIFE RESEARCH, 2014, 23 : 68 - 68
  • [36] Kras Alteration and Overall Survival of Advanced Colorectal Cancer
    Hu, Kun
    Hu, Wenwei
    Lin, Yong
    Feng, Zhaohui
    Gao, Nan
    Zhang, Lanjing
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 681 - 682
  • [37] Kras Alteration and Overall Survival of Advanced Colorectal Cancer
    Hu, Kun
    Hu, Wenwei
    Lin, Yong
    Feng, Zhaohui
    Gao, Nan
    Zhang, Lanjing
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 681 - 682
  • [38] Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
    Turner, N. C.
    Slamon, D. J.
    Ro, J.
    Bondarenko, I
    Im, S-A
    Masuda, N.
    Colleoni, M.
    DeMichele, A.
    Loi, S.
    Verma, S.
    Iwata, H.
    Harbeck, N.
    Loibl, S.
    Andre, F.
    Puyana Theall, K.
    Huang, X.
    Giorgetti, C.
    Huang Bartlett, C.
    Cristofanilli, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (20): : 1926 - 1936
  • [39] Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
    Dai, Wei Fang
    Beca, Jaclyn
    Guo, Helen
    Isaranawatchai, Wanrudee
    Schwartz, Deborah
    Naipaul, Rohini
    Arias, Jessica
    Qiao, Yao
    Gavura, Scott
    Redmond-Misner, Ruby
    Ismail, Zahra
    Barbera, Lisa
    Chan, Kelvin
    CANCER MEDICINE, 2020, 9 (01): : 215 - 224
  • [40] CLINICAL PREDICTIVE FACTORS OF INCREASE OVERALL SURVIVAL WITH BEVACIZUMAB/IRINOTECAN FOR PRIMARY RECURRENT GLIOBLASTOMA (GBM)
    Frenel, J. S.
    Leux, C.
    Tollec, S.
    Martin, S.
    Labbe, C.
    Loussouarn, D.
    Campone, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 330 - 330
12345